top of page
Working at home

First Over-the-Counter Vaginal Oestrogen Cream Now Available in the UK at Boots

In a groundbreaking development for women's healthcare, Ovesse, a vaginal oestrogen cream, has become the first of its kind to be made available over-the-counter in the UK. This new offering provides a much-needed solution for millions of postmenopausal women suffering from vaginal atrophy—a condition that affects approximately 50% of women after menopause.


What is Ovesse?


Ovesse is a prescription-strength vaginal cream containing estriol, a naturally occurring oestrogen hormone. The cream is specifically designed to treat vaginal atrophy, a condition caused by the decrease in oestrogen production following menopause. Symptoms of vaginal atrophy include dryness, discomfort, and painful intercourse, which can significantly impact a woman's quality of life.


Applied directly to the vagina using a reusable applicator, Ovesse delivers localised hormone therapy exactly where it’s needed, offering targeted relief while minimising systemic hormone exposure.


How It Works


Ovesse follows a simple two-phase treatment plan:

  • Initial Phase: One application daily for two weeks.

  • Maintenance Phase: One application twice weekly for ongoing symptom management.

This regimen ensures effective symptom relief while reducing the hormone dosage required over time.


Increased Accessibility for Women


The availability of Ovesse without a prescription represents a significant shift in menopause care. Postmenopausal women can now purchase the cream directly from Boots pharmacies, both in-store and online, eliminating the need for a doctor’s appointment or prescription.


This increased accessibility is expected to empower women to address their symptoms more proactively, reducing the barriers often associated with seeking medical advice and offering a discreet, convenient way to improve their quality of life and intimate relationships.


Nicholas Scott, Head of Northern Europe Commercial at Aspen Pharmacare, emphasised the importance of this step, stating:

"We’re delighted to launch Ovesse vaginal cream in the UK as a non-prescription option for postmenopausal women experiencing symptoms of vaginal atrophy. We know that speaking to a doctor or getting a prescription can sometimes deter women from seeking help. Ovesse will improve access to this healthcare product and empower women to manage their health with greater ease and confidence."

A Growing Recognition of Menopause Health


The introduction of over-the-counter Ovesse reflects a growing acknowledgment of the need for accessible menopause-related healthcare solutions. By offering this treatment without the requirement of a prescription, it helps destigmatize discussions around menopausal symptoms and encourages more women to seek the care they need.


While Ovesse is a significant step forward, it’s important to note that it may not be suitable for everyone. Women should consult with a pharmacist or healthcare professional if they have concerns or specific health conditions before using the cream.


Looking Ahead


The launch of Ovesse at Boots marks a pivotal moment in addressing the healthcare needs of postmenopausal women. It paves the way for further innovation and accessibility in treatments for menopausal symptoms, empowering women to take charge of their well-being during this transformative stage of life.

As conversations around menopause become more open and inclusive, developments like Ovesse underscore the importance of prioritizing women's health and breaking down barriers to care.


For more information, visit your nearest Boots pharmacy or shop online to access this revolutionary treatment.

Comments


bottom of page